Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
7680687970013
CH-68797
Konzentrat
Associated product:
ELZONRIS conc perf 1 mg/ml flac 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
50.0 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.98 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 16973.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2024
Authorization holder
Stemline Therapeutics Switzerland GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 68797
- Drug name
- Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XX67
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 03/02/2023
- Authorization expiration date
- 02/02/2028
- IT Number
- 07.16.4.
- Domain
- Human medicine
Package details
- Description (FR)
- ELZONRIS conc perf 1 mg/ml flac 1 ml
- Description (DE)
- ELZONRIS Inf Konz 1 mg/ml Durchstf 1 ml
- Market launch
- 03/02/2023
- Narcotic (BTM)
- No